These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 20079752

  • 1. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease.
    Bales KR.
    Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death.
    Bruinsma IB, Wilhelmus MM, Kox M, Veerhuis R, de Waal RM, Verbeek MM.
    Brain Res; 2010 Feb 22; 1315():169-80. PubMed ID: 20034483
    [Abstract] [Full Text] [Related]

  • 3. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
    Mann KM, Thorngate FE, Katoh-Fukui Y, Hamanaka H, Williams DL, Fujita S, Lamb BT.
    Hum Mol Genet; 2004 Sep 01; 13(17):1959-68. PubMed ID: 15229191
    [Abstract] [Full Text] [Related]

  • 4. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J, Donkin J, Wellington C.
    Biofactors; 2009 Sep 01; 35(3):239-48. PubMed ID: 19472365
    [Abstract] [Full Text] [Related]

  • 5. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain.
    Ramassamy C, Averill D, Beffert U, Theroux L, Lussier-Cacan S, Cohn JS, Christen Y, Schoofs A, Davignon J, Poirier J.
    Neurobiol Dis; 2000 Feb 01; 7(1):23-37. PubMed ID: 10671320
    [Abstract] [Full Text] [Related]

  • 6. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J, Petanceska SS, Montine TJ, Holtzman DM, Schmidt SD, Parker CA, Callahan MJ, Lipinski WJ, Bisgaier CL, Turner BA, Nixon RA, Martins RN, Ouimet C, Smith JD, Davies P, Laska E, Ehrlich ME, Walker LC, Mathews PM, Gandy S.
    J Neurochem; 2004 Aug 01; 90(4):1011-8. PubMed ID: 15287908
    [Abstract] [Full Text] [Related]

  • 7. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L, Chen L, Ng HK, Pang CP.
    Microsc Res Tech; 2000 Aug 15; 50(4):278-81. PubMed ID: 10936880
    [Abstract] [Full Text] [Related]

  • 8. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?
    Patil SP, Ballard R, Sanchez S, Osborn J, Santangelo D.
    Med Hypotheses; 2012 Apr 15; 78(4):494-6. PubMed ID: 22285195
    [Abstract] [Full Text] [Related]

  • 9. The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase.
    Darreh-Shori T, Modiri N, Blennow K, Baza S, Kamil C, Ahmed H, Andreasen N, Nordberg A.
    Neurobiol Aging; 2011 Jul 15; 32(7):1236-48. PubMed ID: 19713000
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
    Kamboh MI.
    Hum Biol; 1995 Apr 15; 67(2):195-215. PubMed ID: 7729825
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein E in the brain and its role in Alzheimer's disease.
    Poirier J.
    J Psychiatry Neurosci; 1996 Mar 15; 21(2):128-34. PubMed ID: 8820179
    [Abstract] [Full Text] [Related]

  • 12. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
    Dodart JC, Marr RA, Koistinaho M, Gregersen BM, Malkani S, Verma IM, Paul SM.
    Proc Natl Acad Sci U S A; 2005 Jan 25; 102(4):1211-6. PubMed ID: 15657137
    [Abstract] [Full Text] [Related]

  • 13. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.
    Neurosci Lett; 2005 Feb 25; 375(1):1-6. PubMed ID: 15664112
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease.
    Basso M, Gelernter J, Yang J, MacAvoy MG, Varma P, Bronen RA, van Dyck CH.
    Neurobiol Aging; 2006 Oct 25; 27(10):1416-24. PubMed ID: 16182410
    [Abstract] [Full Text] [Related]

  • 15. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease.
    Poirier J.
    Neurobiol Aging; 2005 Mar 25; 26(3):355-61. PubMed ID: 15639314
    [Abstract] [Full Text] [Related]

  • 16. APOE and cholesterol homeostasis in Alzheimer's disease.
    Leduc V, Jasmin-Bélanger S, Poirier J.
    Trends Mol Med; 2010 Oct 25; 16(10):469-77. PubMed ID: 20817608
    [Abstract] [Full Text] [Related]

  • 17. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    Vuletic S, Peskind ER, Marcovina SM, Quinn JF, Cheung MC, Kennedy H, Kaye JA, Jin LW, Albers JJ.
    J Neurosci Res; 2005 May 01; 80(3):406-13. PubMed ID: 15795933
    [Abstract] [Full Text] [Related]

  • 18. Alzheimer's disease: the cholesterol connection.
    Puglielli L, Tanzi RE, Kovacs DM.
    Nat Neurosci; 2003 Apr 01; 6(4):345-51. PubMed ID: 12658281
    [Abstract] [Full Text] [Related]

  • 19. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J, Walker LC, Schroeder E, Vogelgesang S, Stausske D, Walther R, Warzok RW.
    Acta Neuropathol; 2003 Jan 01; 105(1):25-9. PubMed ID: 12471457
    [Abstract] [Full Text] [Related]

  • 20. Fatty acids, lipid metabolism and Alzheimer pathology.
    Hooijmans CR, Kiliaan AJ.
    Eur J Pharmacol; 2008 May 06; 585(1):176-96. PubMed ID: 18378224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.